Medicine and Dentistry
ANCA Associated Vasculitis
100%
Hazard Ratio
44%
Cardiovascular System
32%
Cardiovascular Disease
28%
Vasculitis
26%
Cohort Analysis
25%
Myeloperoxidase
23%
Anticoagulation
23%
Immunoglobulin A Nephropathy
23%
Urinary System
23%
Nephrotic Syndrome
23%
Thromboembolism
23%
Patient-Reported Outcome
23%
Kidney Injury
23%
Systemic Lupus Erythematosus
23%
End Stage Renal Disease
22%
Implantable Automatic Defibrillator
13%
Complement Factor H
13%
Chronic Kidney Disease
12%
Heart Ventricle Arrhythmia
11%
Kidney Function
9%
Visual Analog Scale
8%
Cumulative Incidence
7%
Heart Arrest
7%
Disease Activity
6%
Heart Failure
6%
Brain Ischemia
6%
Pulmonary Embolism
6%
Symptom
5%
Urinary Excretion
5%
Mannose Binding Lectin
5%
Keyphrases
ANCA-associated Vasculitis
59%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
47%
Anti-glomerular Basement Membrane Disease
23%
Proximal Tubule Dysfunction
23%
Increased Incidence
23%
Binding Cleft
23%
Long-term Cardiovascular Outcomes
23%
Outcome Trends
23%
PR3-ANCA
23%
Confidence Interval
23%
Cardiovascular Disease Risk
23%
Proteinase 3
23%
Improved Survival
23%
Autoimmune Vasculitis
23%
Antibody-associated
22%
Proteinase-3 Antibodies
17%
Myeloperoxidase Antibodies
15%
Hazard Ratio
14%
Complement Factor H
13%
DPB1
9%
Major Adverse Cardiovascular Events
8%
Cardiovascular Outcomes
8%
Mean Standard Deviation
7%
Absolute Risk
7%
End-stage Renal Disease
7%
Risk Ratio
7%
Antibody Test
7%
Antineutrophil Cytoplasmic Antibody
7%
Cardiovascular Disease
6%
Cardiac Arrest
5%
Ventricular Arrhythmia
5%
Cardioverter-defibrillator Implantation
5%
Membrane Attack Complex
5%